Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands

AIDS Res Hum Retroviruses. 1994 Jan;10(1):91-6. doi: 10.1089/aid.1994.10.91.

Abstract

The so-called cosmopolitan strains of human T cell leukemia/lymphotropic virus type I (HTLV-I) from Japan, Africa, the West Indies, and the Americas differ only slightly (< 3%) in their genomic sequence. On the other hand, the Melanesian strains of HTLV-I are somewhat more divergent, exhibiting only 93% sequence similarity with the cosmopolitan strains. Despite this difference, sera from individuals infected with Melanesian strains cross-react with T cells infected with cosmopolitan strains of HTLV-I, indicating an overall conservation of the B cell immunoprevalent epitopes. Neutralizing antibodies against HTLV-I in sera from virus-infected Africans and Melanesians were assayed by determining their ability to block the formation of syncytia in cocultures of 8166 and T cell lines harboring either cosmopolitan or Melanesian HTLV-I isolates. All six African sera blocked the formation of syncytia with cells infected with HTLV-IC91-PL, a viral isolate from the United States. Similarly, all six Melanesian sera inhibited syncytium formation with cells infected with HTLV-IMEL3, a virus isolate from the Solomon Islands. Although most of these sera inhibited syncytium formation in cell cultures carrying the cosmopolitan as well as the Melanesian HTLV-I strains, neutralizing antibody titers tended to be higher against the homologous virus. All sera failed to inhibit syncytium formation when cells were infected with HTLV-II. These data indicate the involvement of one or more epitopes in syncytial formation, some of which are conserved in all strains of HTLV-I.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH terms

  • Africa
  • Cell Line
  • Cross Reactions
  • Giant Cells / microbiology
  • HTLV-I Antibodies / immunology*
  • HTLV-I Infections / immunology
  • HTLV-I Infections / pathology
  • Human T-lymphotropic virus 1 / immunology*
  • Human T-lymphotropic virus 1 / isolation & purification
  • Humans
  • Melanesia
  • Neutralization Tests
  • Species Specificity
  • Viral Envelope Proteins / biosynthesis

Substances

  • HTLV-I Antibodies
  • Viral Envelope Proteins